Published in Pediatr Infect Dis J on February 01, 2014
Protective immunogenicity of group A streptococcal M-related proteins. Clin Vaccine Immunol (2015) 0.89
Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations. Curr Treat Options Cardiovasc Med (2017) 0.75
Prevalence of group a streptococcus pharyngeal carriage and clinical manifestations in school children aged 5-15 yrs in Wakiso District, Uganda. BMC Infect Dis (2017) 0.75
Rationale and design of the African group A streptococcal infection registry: the AFROStrep study. BMJ Open (2016) 0.75
Epidemiology of pharyngitis as reported by Zambian school children and their families: implications for demand-side interventions to prevent rheumatic heart disease. BMC Infect Dis (2017) 0.75
Current knowledge of type-specific M antigens of group A streptococci. J Immunol (1962) 14.71
The global burden of group A streptococcal diseases. Lancet Infect Dis (2005) 13.58
Group A streptococcal infections and acute rheumatic fever. N Engl J Med (1991) 4.20
Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis (2009) 3.51
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. Vaccine (2011) 1.98
Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J (2009) 1.65
Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol (2013) 1.59
Rheumatic fever in indigenous Australian children. J Paediatr Child Health (2010) 1.36
Potential coverage of a multivalent M protein-based group A streptococcal vaccine. Vaccine (2013) 1.32
Systematic Review: Estimation of global burden of non-suppurative sequelae of upper respiratory tract infection: rheumatic fever and post-streptococcal glomerulonephritis. Trop Med Int Health (2011) 1.16
Rheumatic heart disease in indigenous populations--New Zealand experience. Heart Lung Circ (2010) 0.93
Prevention and treatment of rheumatic heart disease in the developing world. Nat Rev Cardiol (2009) 0.92
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch Intern Med (2012) 3.96
Current status and future prospects of epidemiology and public health training and research in the WHO African region. Int J Epidemiol (2012) 3.60
Achieving the health Millennium Development Goals for South Africa: challenges and priorities. Lancet (2009) 3.35
Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin Infect Dis (2005) 3.06
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun (2002) 2.74
Beta-blockers for hypertension. Cochrane Database Syst Rev (2012) 2.67
Aetiology and risk factors of peripartum cardiomyopathy: a systematic review. Int J Cardiol (2008) 2.51
Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. PLoS Genet (2010) 2.39
Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J (2010) 2.34
Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial. JAMA (2004) 2.19
A cost-effective strategy for primary prevention of acute rheumatic fever and rheumatic heart disease in children with pharyngitis. S Afr Med J (2013) 2.01
Epidemiology and etiology of cardiomyopathy in Africa. Circulation (2005) 1.95
Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation (2015) 1.95
Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002. Clin Infect Dis (2004) 1.95
Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States. Clin Infect Dis (2006) 1.92
Is primary prevention of rheumatic fever the missing link in the control of rheumatic heart disease in Africa? Circulation (2009) 1.86
Heart failure in sub-saharan Africa: time for action. J Am Coll Cardiol (2007) 1.85
Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am J Cardiol (2010) 1.75
Mutations in FAM111B cause hereditary fibrosing poikiloderma with tendon contracture, myopathy, and pulmonary fibrosis. Am J Hum Genet (2013) 1.70
Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J (2009) 1.65
Towards a uniform plan for the control of rheumatic fever and rheumatic heart disease in Africa--the Awareness Surveillance Advocacy Prevention (A.S.A.P.) Programme. S Afr Med J (2006) 1.59
Primary prevention of acute rheumatic fever and rheumatic heart disease with penicillin in South African children with pharyngitis: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes (2013) 1.59
Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates. Clin Infect Dis (2009) 1.59
Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol (2013) 1.59
Epidemiology of heart failure in sub-Saharan Africa. Expert Rev Cardiovasc Ther (2009) 1.59
Beta-blockers for hypertension. Cochrane Database Syst Rev (2012) 1.56
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Cardiovascular disease in sub-Saharan Africa. Circulation (2005) 1.50
Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res (2002) 1.50
Dynamic epidemiology of group A streptococcal serotypes. Lancet (2002) 1.50
Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord (2005) 1.46
Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci. Ann Med (2002) 1.45
Prevalence of myocarditis and cardiotropic virus infection in Africans with HIV-associated cardiomyopathy, idiopathic dilated cardiomyopathy and heart transplant recipients: a pilot study: cardiovascular topic. Cardiovasc J Afr (2013) 1.41
Motion-guided segmentation for cine DENSE MRI. Med Image Anal (2008) 1.40
Recent advances in the epidemiology, pathogenesis and prognosis of acute heart failure and cardiomyopathy in Africa. Heart (2013) 1.30
The 10 'Best Buys' to combat heart disease, diabetes and stroke in Africa. Heart (2013) 1.29
Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein. Mol Microbiol (2006) 1.29
How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis. J Hypertens (2006) 1.28
Cardiac manifestations of HIV infection: an African perspective. Nat Clin Pract Cardiovasc Med (2008) 1.27
Frequency and clinical genetics of familial dilated cardiomyopathy in Cape Town: implications for the evaluation of patients with unexplained cardiomyopathy. S Afr Med J (2011) 1.27
A modern approach to tuberculous pericarditis. Prog Cardiovasc Dis (2007) 1.26
Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa. Heart Rhythm (2009) 1.20
Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop. Clin Infect Dis (2005) 1.20
Clinical characteristics and outcomes of familial and idiopathic dilated cardiomyopathy in Cape Town: a comparative study of 120 cases followed up over 14 years. S Afr Med J (2011) 1.20
Rationale and design of a Global Rheumatic Heart Disease Registry: the REMEDY study. Am Heart J (2012) 1.20
Relationship between expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm formation in Streptococcus pyogenes. PLoS One (2009) 1.18
STK39 polymorphisms and blood pressure: an association study in British Caucasians and assessment of cis-acting influences on gene expression. BMC Med Genet (2009) 1.17
Echocardiographic screening for subclinical rheumatic heart disease remains a research tool pending studies of impact on prognosis. Curr Cardiol Rep (2013) 1.16
Cardiac involvement in HIV-infected people living in Africa: a review. Cardiovasc J S Afr (2003) 1.15
Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol (2012) 1.14
The importance of the group a streptococcus capsule in the pathogenesis of human infections: a historical perspective. Clin Infect Dis (2008) 1.13
Group A streptococcal vaccines: paving a path for accelerated development. Vaccine (2013) 1.12
Association between common polymorphisms of the proopiomelanocortin gene and body fat distribution: a family study. Diabetes (2005) 1.11
A systematic overview of prospective cohort studies of cardiovascular disease in sub-Saharan Africa. Cardiovasc J Afr (2011) 1.11
3D myocardial tissue tracking with slice followed cine DENSE MRI. J Magn Reson Imaging (2008) 1.09
Coronary artery disease-related genetic variant on chromosome 10q11 is associated with carotid intima-media thickness and atherosclerosis. Arterioscler Thromb Vasc Biol (2010) 1.09
Intramuscular penicillin is more effective than oral penicillin in secondary prevention of rheumatic fever--a systematic review. S Afr Med J (2003) 1.09
Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis. Tuberculosis (Edinb) (2011) 1.08
Letter by Karthikeyan et al regarding article, "Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia, 1997 to 2010". Circulation (2014) 1.07
Evaluating the causal relevance of diverse risk markers: horizontal systematic review. BMJ (2009) 1.02
A comparison of cases of paediatric-onset and adult-onset cryptococcosis detected through population-based surveillance, 2005-2007. AIDS (2012) 1.02
Rheumatic fever: neglected again. Science (2009) 1.01
Ambulatory blood pressure is associated with polymorphic variation in P2X receptor genes. Hypertension (2008) 1.01
Four genetic loci influencing electrocardiographic indices of left ventricular hypertrophy. Circ Cardiovasc Genet (2011) 0.99
Molecular genetics of cardiomyopathy: changing times, shifting paradigms. Cardiovasc J S Afr (2003) 0.98
Genetic susceptibility to acute rheumatic fever: a systematic review and meta-analysis of twin studies. PLoS One (2011) 0.97
Controlling rheumatic heart disease in developing countries. Cardiovasc J S Afr (2006) 0.97
The burden of antenatal heart disease in South Africa: a systematic review. BMC Cardiovasc Disord (2012) 0.97
HIV-1 infection alters CD4+ memory T-cell phenotype at the site of disease in extrapulmonary tuberculosis. Eur J Immunol (2012) 0.97
Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections. Infect Immun (2004) 0.94
Tuberculous pericarditis with and without HIV. Heart Fail Rev (2013) 0.93
Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes. Vaccine (2010) 0.92
Inactivation of DltA modulates virulence factor expression in Streptococcus pyogenes. PLoS One (2009) 0.92
Medical therapy of pericardial diseases: part I: idiopathic and infectious pericarditis. J Cardiovasc Med (Hagerstown) (2010) 0.90
Mapping the fibrinogen-binding domain of serum opacity factor of group a streptococci. Curr Microbiol (2002) 0.90
Myopericarditis in tuberculous pericardial effusion: prevalence, predictors and outcome. Heart (2013) 0.90
Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci. Infect Immun (2003) 0.89
Progress in group A streptococcal vaccine development. Pediatr Infect Dis J (2004) 0.88
The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation. Circulation (2016) 0.87
Progress toward a global group a streptococcal vaccine. Pediatr Infect Dis J (2013) 0.87
Cardiomyopathies and myocardial disorders in Africa: present status and the way forward. Cardiovasc J Afr (2013) 0.87
Identification of Cadherin 2 (CDH2) Mutations in Arrhythmogenic Right Ventricular Cardiomyopathy. Circ Cardiovasc Genet (2017) 0.87
HIV infection is associated with a lower incidence of constriction in presumed tuberculous pericarditis: a prospective observational study. PLoS One (2008) 0.87
Gender differences in clinical characteristics and outcome of acute heart failure in sub-Saharan Africa: results of the THESUS-HF study. Clin Res Cardiol (2015) 0.86
Rheumatic heart disease: social and economic dimensions. S Afr Med J (2008) 0.86
Lack of adherence to the national guidelines on the prevention of rheumatic fever. S Afr Med J (2005) 0.86
Readmission and death after an acute heart failure event: predictors and outcomes in sub-Saharan Africa: results from the THESUS-HF registry. Eur Heart J (2013) 0.86
The prevalence and outcome of effusive constrictive pericarditis: a systematic review of the literature. Cardiovasc J Afr (2012) 0.85
Streptococcal pharyngitis in schoolchildren in Bamako, Mali. Pediatr Infect Dis J (2015) 0.85
Prevalence, hemodynamics, and cytokine profile of effusive-constrictive pericarditis in patients with tuberculous pericardial effusion. PLoS One (2013) 0.84
Genetic basis of rifampicin resistance in methicillin-resistant Staphylococcus aureus suggests clonal expansion in hospitals in Cape Town, South Africa. BMC Microbiol (2012) 0.84
The history of the Pan-African Society of Cardiology (PASCAR): the first 30 years, 1981-2011. Cardiovasc J Afr (2011) 0.84